We were thrilled to participate in last weekend’s #Move4PD to raise awareness & support the #Parkinsons community. Our team is working tirelessly on a treatment to improve symptoms of the disease - learn about our ongoing trial: sunrisepd.com

We're leading the charge in targeting #neuroinflammation - a root cause of Alzheimer’s, Parkinson’s & long COVID. Cuong Do, BioVie's CEO, joins The Longevity Formula podcast to discuss BioVie’s novel approach with bezisterim. Listen: podcasts.apple.com/us/podcast/the… #longevity #biotech

REMINDER: Join us today at 12pm EDT for a virtual event to learn more about the urgent unmet needs and treatment landscape in #ParkinsonsDisease and our ongoing SUNRISE-PD clinical trial in newly diagnosed patients. Register here: lifescievents.com/event/biovie-4/ $BIVI #Neuroscience

Alzheimer’s disease is the 7th leading cause of death globally – yet, despite decades of effort, there are significant gaps in the fight to #ENDALZ. We’re joining Alzheimer's Association this month in raising awareness. Learn more: alz.org/abam/overview.… #AlzheimersAwareness

Everyone has been impacted by Alzheimer’s or knows someone who has. In honor of Alzheimer’s & Brain Awareness Month, #GoPurple and learn how you can take action to #ENDALZ: alz.org/abam.

Last week we held a virtual KOL event with two leading experts in the field to discuss the unmet need in #ParkinsonsDisease along with an overview of our currently enrolling SUNRISE-PD trial in newly diagnosed patients. Catch the replay here: lifescievents.com/event/biovie-4/ $BIVI

June is Alzheimer’s & Brain Health Awareness Month, a time to spotlight not only Alzheimer’s but also the broader challenges facing brain health, including Parkinson’s disease. Learn more at sunrisePD.com #ParkinsonsAwareness #BrainHealthMonth #NeuroInnovation

🚀 BioVie Inc. $BIVI: Targeting Major Breakthroughs in Neurology & Liver Disease $BIVI is advancing innovative therapies in high-need markets, including Alzheimer’s, Parkinson’s, Long COVID, and liver cirrhosis. With multiple clinical-stage assets and a fully funded Parkinson’s

A new #LongCovid clinical trial is enrolling for bezisterim, an investigational anti-inflammatory drug that crosses the blood-brain barrier. It has been studied in neurological & neurodegenerative disorders, including Alzheimer’s & Parkinson’s. 1/

We will be presenting a poster at #ATMRD highlighting the decentralized design of our Phase 2 SUNRISE-PD clinical trial evaluating bezisterim (NE3107) in early Parkinson’s disease. Learn more: investors.bioviepharma.com/news/news-deta… #ParkinsonsDisease #MovementDisorders $BIVI

At #ATMRD2025, researchers presented the design of the ongoing phase 2 SUNRISE-PD trial, assessing the safety and efficacy of investigational bezisterim on motor and nonmotor symptoms in patients with early-stage #PD. BioVie Inc Parkinson & Movement Disorder Alliance Read More:

Dr. Mark Stacy highlighted the potential of bezisterim as a treatment targeting #neuroinflammation in Parkinson's disease & its innovative P2 trial design on Practical Neurology’s podcast. Listen here: practicalneurology.com/diseases-diagn… #ParkinsonsAwareness #BrainHealthMonth $BIVI

Register for “ADDRESS-LC Trial: Studying the Impact of #Bezisterim on #BrainFog & #Fatigue in People w/ #LongCovid.” We'll discuss how to join & implications for #MECFS. 7.22 @ 3 pm PT/6 pm ET ow.ly/LuQ450WiKtY

In a keynote session today at #ARC2025, we presented data highlighting bezisterim’s potential to target epigenetic-driven age acceleration as a treatment for #Alzheimers and other #neurodegenerative diseases of aging. Learn more here: investors.bioviepharma.com/news/news-deta… #Neuroscience $BIVI

We’re thrilled to announce the appointment of Amy S. Chappell, MD, FAAN, and Kameel D. Farag to our Board of Directors. Details: investors.bioviepharma.com/news/news-deta… #Biotech #Neuroinflammation #Neurology $BIVI

We presented data that suggest bezisterim’s potential to target epigenetic-driven age deceleration as a treatment for #Alzheimers disease and other #neurodegenerative diseases of aging. Learn more: investors.bioviepharma.com/news/news-deta… #Aging #Longevitiy #Neuroscience $BIVI